Načítá se...
Beta-lactamase inhibitors from laboratory to clinic.
beta-Lactamases constitute the major defense mechanism of pathogenic bacteria against beta-lactam antibiotics. When the beta-lactam ring of this antibiotic class is hydrolyzed, antimicrobial activity is destroyed. Although beta-lactamases have been identified with clinical failures for over 40 years...
Uloženo v:
| Vydáno v: | Clin Microbiol Rev |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Society for Microbiology (ASM)
1988
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC358033/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3060240/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/cmr.1.1.109 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|